The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth

By Tae Hyun-Jin   Kim Ji   Park Sungha   Tomiya Noboru   Li Geng   Wei Wen   Petrashevskaya Natalia   Ahmet Ismayil   Pang John   Cruschwitz Stefanie   Riebe Rebecca   Zhang Yinghua   Morrell Christopher   Browe David   Lee Yuan   Xiao Rui-ping   Talan Mark   Lakatta Edward   Lin Li  

Journal of Molecular Medicine, Vol. 91, Iss. 12, 2013-12 ,pp. : 1369-1381

Springer Publishing Company

Access to resources Recommend Favorite

The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation

By Bowman Marion   Schmidt Ann  

Journal of Molecular Medicine, Vol. 91, Iss. 12, 2013-12 ,pp. : 1329-1331

Springer Publishing Company

Access to resources Recommend Favorite

The Pathogenesis, Complications and Therapeutic Strategy for Hepatitis C Virus-associated Insulin Resistance in the Era of Anti-viral Treatment

By  

Reviews on Recent Clinical Trials, Vol. 5, Iss. 3, 2010-09 ,pp. : 147-157

Bentham Science Publishers

Access to resources Recommend Favorite

The RAGE connection to diabetes and atherosclerosis: an intertwined web of advanced glycation and inflammation

By Ramasamy Ravichandran   Yan Shi Fang   Schmidt Ann Marie  

Future Lipidology, Vol. 2, Iss. 2, 2007-04 ,pp. : 239-250

Future Medicine

Access to resources Recommend Favorite

Emerging Therapeutic Targets in Osteoncology

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 223-224

Karger

Access to resources Recommend Favorite